Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 2699

1.

Time to Give Up on Cardioprotection? A Critical Appraisal of Clinical Studies on Ischemic Pre-, Post-, and Remote Conditioning.

Heusch G, Rassaf T.

Circ Res. 2016 Aug 19;119(5):676-95. doi: 10.1161/CIRCRESAHA.116.308736. Review.

PMID:
27539973
2.

The role of trimetazidine in cardiovascular disease: beyond an anti-anginal agent.

McCarthy CP, Mullins KV, Kerins DM.

Eur Heart J Cardiovasc Pharmacother. 2015 Dec 9. pii: pvv051. [Epub ahead of print] Review.

3.

Sevoflurane preconditioning in on-pump coronary artery bypass grafting: a meta-analysis of randomized controlled trials.

Lu Y, Wang L, Liu N, Dong T, Li R.

J Anesth. 2016 Aug 16. [Epub ahead of print]

PMID:
27531076
4.

RNAi-Based Therapy in Experimental Ischemia-Reperfusion Injury: The New Targets.

de Ramon L, Jarque M, Ripoll E, Bestard O, Grinyo JM, Torras J.

Curr Pharm Des. 2016 Jul 19. [Epub ahead of print]

PMID:
27510493
5.

Opioids in Remote Ischemic Preconditioning-Induced Cardioprotection.

Randhawa PK, Jaggi AS.

J Cardiovasc Pharmacol Ther. 2016 Jul 26. pii: 1074248416660621. [Epub ahead of print]

PMID:
27459954
6.

Cardioprotection by Conditioning Mimetic Drugs.

Santillo E, Migale M, Postacchini D, Balestrini F, Incalzi RA.

Antiinflamm Antiallergy Agents Med Chem. 2016 Jul 19. [Epub ahead of print]

PMID:
27439628
7.

SIRT3 in cardiovascular diseases: Emerging roles and therapeutic implications.

Lu Y, Wang YD, Wang XY, Chen H, Cai ZJ, Xiang MX.

Int J Cardiol. 2016 Oct 1;220:700-5. doi: 10.1016/j.ijcard.2016.06.236. Epub 2016 Jun 29. Review.

PMID:
27393852
8.

PARP inhibition and postinfarction myocardial remodeling.

Halmosi R, Deres L, Gal R, Eros K, Sumegi B, Toth K.

Int J Cardiol. 2016 Aug;217 Suppl:S52-9. doi: 10.1016/j.ijcard.2016.06.223. Epub 2016 Jun 28.

PMID:
27392900
9.

A critical review on the translational journey of cardioprotective therapies!

Rossello X, Yellon DM.

Int J Cardiol. 2016 Oct 1;220:176-84. doi: 10.1016/j.ijcard.2016.06.131. Epub 2016 Jun 25. Review.

PMID:
27379920
10.

Targeting the Innate Immune Response to Improve Cardiac Graft Recovery after Heart Transplantation: Implications for the Donation after Cardiac Death.

Toldo S, Quader M, Salloum FN, Mezzaroma E, Abbate A.

Int J Mol Sci. 2016 Jun 17;17(6). pii: E958. doi: 10.3390/ijms17060958. Review.

11.

Mitochondrial function in hypoxic ischemic injury and influence of aging.

Ham PB 3rd, Raju R.

Prog Neurobiol. 2016 Jun 16. pii: S0301-0082(15)30065-4. doi: 10.1016/j.pneurobio.2016.06.006. [Epub ahead of print] Review.

PMID:
27321753
12.

Mitochondria-Targeted Antioxidants: Future Perspectives in Kidney Ischemia Reperfusion Injury.

Kezic A, Spasojevic I, Lezaic V, Bajcetic M.

Oxid Med Cell Longev. 2016;2016:2950503. doi: 10.1155/2016/2950503. Epub 2016 May 24. Review.

13.

The Role of Oxidative Stress in Myocardial Ischemia and Reperfusion Injury and Remodeling: Revisited.

Kurian GA, Rajagopal R, Vedantham S, Rajesh M.

Oxid Med Cell Longev. 2016;2016:1656450. doi: 10.1155/2016/1656450. Epub 2016 May 25. Review.

14.

Mitochondrial sirtuins in the heart.

Bugger H, Witt CN, Bode C.

Heart Fail Rev. 2016 Sep;21(5):519-28. doi: 10.1007/s10741-016-9570-7.

PMID:
27295248
15.

Peroxisome Proliferator-Activated Receptor-╬│ Is Critical to Cardiac Fibrosis.

Liu HJ, Liao HH, Yang Z, Tang QZ.

PPAR Res. 2016;2016:2198645. doi: 10.1155/2016/2198645. Epub 2016 May 12. Review.

16.

Caveolin-1/-3: therapeutic targets for myocardial ischemia/reperfusion injury.

Yang Y, Ma Z, Hu W, Wang D, Jiang S, Fan C, Di S, Liu D, Sun Y, Yi W.

Basic Res Cardiol. 2016 Jul;111(4):45. doi: 10.1007/s00395-016-0561-6. Epub 2016 Jun 9. Review.

PMID:
27282376
17.

Fimasartan: A New Angiotensin Receptor Blocker.

Lee HY, Oh BH.

Drugs. 2016 Jul;76(10):1015-22. doi: 10.1007/s40265-016-0592-1. Review.

PMID:
27272555
18.

Altered Nitric Oxide System in Cardiovascular and Renal Diseases.

Lee J, Bae EH, Ma SK, Kim SW.

Chonnam Med J. 2016 May;52(2):81-90. doi: 10.4068/cmj.2016.52.2.81. Epub 2016 May 20. Review.

19.

The emerging role of Toll-like receptor 4 in myocardial inflammation.

Yang Y, Lv J, Jiang S, Ma Z, Wang D, Hu W, Deng C, Fan C, Di S, Sun Y, Yi W.

Cell Death Dis. 2016 May 26;7:e2234. doi: 10.1038/cddis.2016.140. Review.

20.

Inhibition of Myocardial Ischemia/Reperfusion Injury by Exosomes Secreted from Mesenchymal Stem Cells.

Zhang H, Xiang M, Meng D, Sun N, Chen S.

Stem Cells Int. 2016;2016:4328362. doi: 10.1155/2016/4328362. Epub 2016 Apr 26. Review.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk